Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Anticancer Research
|
May 1, 1995
Transcription factors: structure, function, and implication in malignant growth
A G Papavassiliou
Anticancer Research
|
September 1, 1994
The role of regulated phosphorylation in the biological activity of transcription factors SRF and Elk-1/SAP-1
A G Papavassiliou
Anticancer Research
|
November 1, 1993
c-Jun phosphorylation in signal transduction and gene regulation
A G Papavassiliou
Journal of Immunological Methods
|
March 29, 1994
Preservation of protein phosphoryl groups in immunoprecipitation assays
A G Papavassiliou
Molecular Medicine Today
|
October 2, 1998
Transcription-factor-modulating agents: precision and selectivity in drug design
A G Papavassiliou
Anticancer Research
|
September 1, 1994
The CREB/ATF family of transcription factors: modulation by reversible phosphorylation
A G Papavassiliou
Expert Opinion on Investigational Drugs
|
July 5, 2005
The therapeutic potential of targeting drugs at transcription factors
D Kletsas, A G Papavassiliou
Trends in Endocrinology and Metabolism: TEM
|
April 11, 2001
Type 2 diabetes mellitus and worm longevity: a transcriptional link to cure?
I Habeos, A G Papavassiliou
Anticancer Research
|
January 11, 2000
Molecular "rehabilitation" by rational drug targeting: the challenge of P53 in cancer treatment
A Tzatsos, A G Papavassiliou
The Journal of Biological Chemistry
|
January 25, 1990
Characterization of DNA-protein complex formation in nuclear extracts with a sequence from the herpes simplex virus thymidine kinase gene
A G Papavassiliou, S J Silverstein
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Anticancer Research
|
May 1, 1995
Transcription factors: structure, function, and implication in malignant growth
A G Papavassiliou
Anticancer Research
|
September 1, 1994
The role of regulated phosphorylation in the biological activity of transcription factors SRF and Elk-1/SAP-1
A G Papavassiliou
Anticancer Research
|
November 1, 1993
c-Jun phosphorylation in signal transduction and gene regulation
A G Papavassiliou
Journal of Immunological Methods
|
March 29, 1994
Preservation of protein phosphoryl groups in immunoprecipitation assays
A G Papavassiliou
Molecular Medicine Today
|
October 2, 1998
Transcription-factor-modulating agents: precision and selectivity in drug design
A G Papavassiliou
Anticancer Research
|
September 1, 1994
The CREB/ATF family of transcription factors: modulation by reversible phosphorylation
A G Papavassiliou
Expert Opinion on Investigational Drugs
|
July 5, 2005
The therapeutic potential of targeting drugs at transcription factors
D Kletsas, A G Papavassiliou
Trends in Endocrinology and Metabolism: TEM
|
April 11, 2001
Type 2 diabetes mellitus and worm longevity: a transcriptional link to cure?
I Habeos, A G Papavassiliou
Anticancer Research
|
January 11, 2000
Molecular "rehabilitation" by rational drug targeting: the challenge of P53 in cancer treatment
A Tzatsos, A G Papavassiliou
The Journal of Biological Chemistry
|
January 25, 1990
Characterization of DNA-protein complex formation in nuclear extracts with a sequence from the herpes simplex virus thymidine kinase gene
A G Papavassiliou, S J Silverstein
Page
of 6